AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Lyudmila Bazhenova'
:
Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer
Publication Year: 2015
DOI: https://doi.org/10.18632/oncotarget.3472
Abstract:
Add to Library
Authors:
Igor F. Tsigelny
Jennifer J. Wheler
Jerry P. Greenberg
Valentina L. Kouznetsova
David J. Stewart
Lyudmila Bazhenova
Razelle Kurzrock
Abstract CT011: Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
Publication Year: 2021
DOI: https://doi.org/10.1158/1538-7445.am2021-ct011
Abstract:
Add to Library
Authors:
Vivek Subbiah
Bhavana Konda
Todd M. Bauer
Caroline E. McCoach
Gerald S. Falchook
Masayuki Takeda
Jyoti D. Patel
Jared Weiss
Nir Peled
Lyudmila Bazhenova
Victoria Soldatenkova
Pearl Plernjit French
Nora Drove
Oliver Gautschi
Alexander Drilon
Abstract 394: Prognosis and molecular characteristics of patients with TRK fusion cancer in the 100,000 Genomes Project
Publication Year: 2021
DOI: https://doi.org/10.1158/1538-7445.am2021-394
Abstract:
Add to Library
Authors:
John Bridgewater
Xiaolong Jiao
Mounika Parimi
Clare Flach
Jeran K. Stratford
Atanas Kamburov
Arndt Schmitz
Jihong Zong
John A. Reeves
Karen Keating
Amanda Bruno
Marc Fellous
Lyudmila Bazhenova
Abstract CT131: Entrectinib in <i>NTRK</i>-fusion positive (<i>NTRK</i>-FP) non-small cell lung cancer (NSCLC): Integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.am2019-ct131
Abstract:
Add to Library
Authors:
Robert C. Doebele
Luis Paz‐Ares
Anna F. Farago
Stephen V. Liu
Sant P. Chawla
Diégo Tosi
Collin M. Blakely
John C. Krauss
Darren Sigal
Lyudmila Bazhenova
Thomas John
Benjamin Besse
Jürgen Wolf
Takashi Seto
Edna Chow‐Maneval
YE Cheng-lin
Brian Simmons
George D. Demetri
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on <i>BRAF</i>: Case Series and Literature Review of Treatment
Publication Year: 2022
DOI: https://doi.org/10.1200/po.21.00551
Abstract:
Add to Library
Authors:
Nicholas Giustini
Sandip Pravin Patel
Nathaniel J. Myall
José Fernando do Prado Moura
Amit Kulkarni
Richard C. Chao
Heather A. Wakelee
Lyudmila Bazhenova
Abstract 09: Cancers with <i>NTRK</i> gene fusions: Molecular characteristics and prognosis
Publication Year: 2020
DOI: https://doi.org/10.1158/1557-3265.advprecmed20-09
Abstract:
Add to Library
Authors:
Lyudmila Bazhenova
Xiaolong Jiao
Andrew Lokker
Jeremy Snider
Emily Castellanos
Shivani Nanda
Virginia Fisher
Jihong Zong
Karen Keating
Marc Fellous
Abstract P225: Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in <i>MET</i>: Update from the Phase 1 SHIELD-1 trial
Publication Year: 2021
DOI: https://doi.org/10.1158/1535-7163.targ-21-p225
Abstract:
Add to Library
Authors:
David S. Hong
Daniel V.T. Catenacci
Lyudmila Bazhenova
Byoung Chul Cho
Mariano Ponz‐Sarvisé
Rebecca S. Heist
Víctor Moreno
Gerald S. Falchook
Viola W. Zhu
Aurélie Swalduz
Benjamin Besse
Dong‐Wan Kim
Shinkyo Yoon
Xiuning Le
Tingting Zhao
Alysha Kadva
Zachary Zimmerman
Jeeyun Lee
Early Noninvasive Detection of Response to Targeted Therapy in Non–Small Cell Lung Cancer
Publication Year: 2018
DOI: https://doi.org/10.1158/0008-5472.can-18-1082
Abstract:
Add to Library
Authors:
Jillian Phallen
Alessandro Leal
Brian Woodward
Patrick M. Forde
Jarushka Naidoo
Kristen A. Marrone
Julie R. Brahmer
Jacob Fiksel
Jamie E. Medina
Stephen Cristiano
Doreen N. Palsgrove
Christopher D. Gocke
Daniel C. Bruhm
Parissa Keshavarzian
Vilmos Adleff
Elizabeth Weihe
Valsamo Anagnostou
Robert B. Scharpf
Victor E. Velculescu
Hatim Husain
Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)
Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.am2019-ct224
Abstract:
Add to Library
Authors:
Edward B. Garon
Alexander I. Spira
Melissa L. Johnson
Lyudmila Bazhenova
Joseph W. Leach
Albert F. Candia
Robert L. Coffman
Mary J. Janatpour
Érick Gamelin
Robert Janssen
Laura Q.M. Chow
Abstract P02-01: Repotrectinib in patients with <i>NTRK</i> fusion-positive advanced solid tumors: update from the registrational phase 2 TRIDENT-1 trial
Publication Year: 2021
DOI: https://doi.org/10.1158/1535-7163.targ-21-p02-01
Abstract:
Add to Library
Authors:
Benjamin Besse
Christina Baik
Christoph Springfeld
Alice Hervieu
Víctor Moreno
Lyudmila Bazhenova
W. Marston Linehan
D. Ross Camidge
Benjamin Solomon
Vamsidhar Velcheti
Anthonie J. van der Wekken
Enriqueta Felip
Dipesh Uprety
Denise Trone
Shanna Stopatschinskaja
Byoung Chul Cho
Alexander Drilon
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology
Publication Year: 2015
DOI: https://doi.org/10.18632/oncotarget.5289
Abstract:
Add to Library
Authors:
Sandip Pravin Patel
Maria Schwaederlé
Gregory A. Daniels
Paul T. Fanta
Richard B. Schwab
Kelly A. Shimabukuro
Santosh Kesari
David Piccioni
Lyudmila Bazhenova
Teresa Helsten
Scott M. Lippman
Barbara A. Parker
Razelle Kurzrock
MA16.11 CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials
Publication Year: 2017
DOI: https://doi.org/10.1016/j.jtho.2016.11.514
Abstract:
Add to Library
Authors:
Glenwood Goss
Chun‐Ming Tsai
Frances A. Shepherd
Myung‐Ju Ahn
Lyudmila Bazhenova
Lucio Crinò
Filippo de Marinis
Enriqueta Felip
Alessandro Morabito
Rachel Hodge
Mireille Cantarini
Tetsuya Mitsudomi
Pasi A. Jänne
James Chih‐Hsin Yang
In memory of Lyudmila Grigor'evna Bazhenova
Publication Year: 2019
DOI: https://doi.org/10.17116/rosakush20191903191
Abstract:
Add to Library
Authors:
Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)
Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.sabcs18-ct224
Abstract:
Add to Library
Authors:
Edward B. Garon
Alexander I. Spira
Melissa Johnson
Lyudmila Bazhenova
Joseph Leach
Albert F. Candia
Robert L. Coffman
Mary J. Janatpour
Érick Gamelin
Robert Janssen
Laura Q.M. Chow
Abstract CT079: ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)
Publication Year: 2016
DOI: https://doi.org/10.1158/1538-7445.am2016-ct079
Abstract:
Add to Library
Authors:
Sai-Hong Ou
Keunchil Park
Ji‐Youn Han
Dong‐Wan Kim
Lyudmila Bazhenova
Yong‐Kek Pang
How Soon Hin
Óscar Juan
Jeewoong Son
Isabelle Voccia
Daniel Massey
Miyoung Kim
Pasi A. Jänne
Found 48 results in 0.136 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"